RecruitingNCT02448485
High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)
High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis
Sponsor
Medical University Innsbruck
Enrollment
10,000 participants
Start Date
Jun 1, 2015
Study Type
OBSERVATIONAL
Conditions
Summary
TASS-2 (Tyrolean Aortic Stenosis Study-2) aims to characterize the clinical value of minimally elevated troponin T plasma levels both in patients with asymptomatic and symtomatic aortic stenosis.
Eligibility
Inclusion Criteria1
- aortic stenosis detected by echocardiography / invasively
Exclusion Criteria2
- acute coronary syndrome
- endocarditis
Interventions
PROCEDUREAortic Valve Intervention (surgical or transcatheter)
Surgical or interventional aortic valve implantation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02448485
Related Trials
Mind Your Heart-II
NCT054311921 location
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location